Literature DB >> 15777383

Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients?

Michael J Veness1, Gary J Morgan, Yasoda Sathiyaseelan, Val Gebski.   

Abstract

BACKGROUND: There is an increasing risk of cervical lymph node metastases as tumour thickness increases in patients with anterior tongue squamous cell carcinoma (SCC). The role of elective neck treatment in early anterior tongue cancer in unclear.
METHODS: Patients diagnosed with anterior tongue cancer and treated with glossectomy +/- neck dissection were identified. The aim was to document the incidence of pathological lymph node metastases and outcome with increasing tumour thickness. The Cox proportional hazards model was used to identify prognostic factors. Survival curves were calculated using the Kaplan-Meier method.
RESULTS: Between 1980 and 2002 99 patients (63 male and 36 female) with anterior tongue SCC were treated at Westmead Hospital, Sydney, and had a documented tumour thickness. Median age at diagnosis was 63 years (23-89 years). Median follow up was 37 months (6-205 months). Sixty-three patients underwent partial glossectomy and neck dissection. Thirty-six underwent partial glossectomy only. At the time of presentation 45/63 (71%) were clinically node negative. Using tumour thickness < or = 5 mm versus > 5 mm the incidence of nodal metastases was 8% versus 51% (P = 0.007). On multivariate analysis pathological nodal involvement and advanced stage both significantly predicted survival. The 2-year disease-free survival difference based on tumour thickness (< or = 5 mm vs > 5 mm) was 76% versus 65% (P = 0.47).
CONCLUSIONS: Elective treatment to the ipsilateral neck is not indicated in all patients with anterior tongue cancer. However, for patients with a tumour thickness > 5 mm it is recommended that they undergo treatment to the ipsilateral neck in the form of a supraomohyoid neck dissection.

Entities:  

Mesh:

Year:  2005        PMID: 15777383     DOI: 10.1111/j.1445-2197.2005.03306.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  13 in total

Review 1.  Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma.

Authors:  Ken Omura
Journal:  Int J Clin Oncol       Date:  2014-04-01       Impact factor: 3.402

2.  Squamous Cell Carcinoma of the Oral Tongue in Young Patients: Outcomes and Implications for Treatment.

Authors:  Narayana Subramaniam; Deepak Balasubramanian; Tsu-Hui Hubert Low; Sivakumar Vidhyadharan; Anjali Menon; Samskruthi Murthy; Krishnakumar Thankappan; Jonathan R Clark; Kan Gao; Subramania Iyer
Journal:  Indian J Surg Oncol       Date:  2020-02-22

3.  The prognostic importance of midline involvement in oral tongue cancer.

Authors:  Shane Lloyd; James B Yu; Lynn D Wilson; Benjamin L Judson; Roy H Decker
Journal:  Am J Clin Oncol       Date:  2012-10       Impact factor: 2.339

4.  Tumour thickness in oral cancer using an intra-oral ultrasound probe.

Authors:  Wouter L Lodder; Hendrik J Teertstra; Ing B Tan; Frank A Pameijer; Ludi E Smeele; Marie-Louise F van Velthuysen; Michiel W M van den Brekel
Journal:  Eur Radiol       Date:  2010-08-03       Impact factor: 5.315

5.  The effect of preoperative neutrophil, platelet and lymphocyte counts on local recurrence and survival in early-stage tongue cancer.

Authors:  Kerem Ozturk; N Serdar Akyildiz; Mustafa Uslu; Sercan Gode; Umit Uluoz
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-17       Impact factor: 2.503

6.  Outcome and fewer indications for adjuvant therapy for patients with oral squamous cell carcinomas under standardized tumor board conditions.

Authors:  Alexander Gröbe; Lena Rybak; Gerhard Schön; Ralf Smeets; Silke Tribius; Philippe Schafhausen; Till S Clauditz; Henning Hanken; Max Heiland
Journal:  J Cancer Res Clin Oncol       Date:  2015-10-27       Impact factor: 4.553

7.  Low PDL1 Expression in Tumour Infiltrating Lymphocytes Predicts Local Recurrence in Oral Squamous Cell Carcinoma.

Authors:  Narayana Subramaniam; Ajit Nambiar; Sujan Dhar; Krishnakumar Thankappan; Manzoor Koyakutty; Deepak Balasubramanian; Manjula Das; Subramania Iyer
Journal:  Indian J Surg Oncol       Date:  2021-04-27

8.  Variable course of progression of oral cavity and oropharyngeal carcinoma in young adults.

Authors:  Maciej Szczepan Pabiszczak; Elżbieta Waśniewska; Daniela Mielcarek-Kuchta; Dorota Miętkiewska-Leszniewska; Małgorzata Wierzbicka; Witold Szyfter
Journal:  Contemp Oncol (Pozn)       Date:  2013-06-28

9.  Primary surgical therapy for locally limited oral tongue cancer.

Authors:  Konstantinos Mantsopoulos; Georgios Psychogios; Julian Künzel; Frank Waldfahrer; Johannes Zenk; Heinrich Iro
Journal:  Biomed Res Int       Date:  2014-05-20       Impact factor: 3.411

Review 10.  Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature.

Authors:  Ewa Majchrzak; Bartosz Szybiak; Anna Wegner; Piotr Pienkowski; Jakub Pazdrowski; Lukasz Luczewski; Marcin Sowka; Pawel Golusinski; Julian Malicki; Wojciech Golusinski
Journal:  Radiol Oncol       Date:  2014-01-22       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.